SacapaƱo, Dante M.
HRN: 21-98-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2024
CEFTRIAXONE 1G (VIAL)
03/05/2024
03/12/2024
IV
1 Gram
Q12H
Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes